Futura Medical PLC
FUM
Company Profile
Business description
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Contact
40 Occam Road
Surrey Technology Centre
GuildfordSurreyGU2 7YG
GBRT: +44 1483685670
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
17
Stocks News & Analysis
stocks
Apple earnings: Strong performance overpowers headwinds, and we raise our FVE
Our view of Apple shares.
stocks
Coles is winning the supermarket wars but is Woollies the better long-term opportunity?
Our view after first quarter sales updates.
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
We think Microsoft stock is moderately undervalued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,182.50 | 24.00 | 0.26% |
| CAC 40 | 8,104.24 | 16.83 | -0.21% |
| DAX 40 | 24,140.00 | 181.70 | 0.76% |
| Dow JONES (US) | 47,262.52 | 300.35 | -0.63% |
| FTSE 100 | 9,710.85 | 6.40 | -0.07% |
| HKSE | 26,158.36 | 251.71 | 0.97% |
| NASDAQ | 23,811.15 | 86.20 | 0.36% |
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% |
| NZX 50 Index | 13,556.30 | 7.98 | 0.06% |
| S&P 500 | 6,837.43 | 2.77 | -0.04% |
| S&P/ASX 200 | 8,894.80 | 36.20 | 0.41% |
| SSE Composite Index | 3,976.52 | 21.73 | 0.55% |